,trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['bcsm', 'thank you', 'breast', 'destiny-breast04']
. , of , stopped by to provide his insights on the practice changing destiny-breast04 study. thank you, dr. iyengar, for speaking with us at ! #asco22 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.